PROFUSA, INC. Deferred Costs, Noncurrent
PROFUSA, INC. (PFSA) had Deferred Costs, Noncurrent of $70.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:DeferredCosts · last filed 2026-08-19
- 2026-06-30: Deferred Costs, Noncurrent $70.00K.
- 2026-03-31: Deferred Costs, Noncurrent $146.00K.
- 2024-12-31: Deferred Costs, Noncurrent $2.76M.
- 2023-12-31: Deferred Costs, Noncurrent $1.53M.
| Period end | Deferred Costs, Noncurrent |
|---|---|
| 2026-06-30 | $70.00K 10-Q · filed 2026-08-19 |
| 2026-03-31 | $146.00K 10-Q · filed 2026-05-15 |
| 2024-12-31 | $2.76M S-1/A · filed 2026-05-01 |
| 2023-12-31 | $1.53M S-1/A · filed 2026-05-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |